HBW Insight is part of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC’s registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction

P&G Asks For Higher Class Action Floor In Align Class Certification Appeal

This article was originally published in The Tan Sheet

Executive Summary

Procter & Gamble petitions the Supreme Court to overturn a decision giving class action certification to a complaint alleging the firm deceived consumers with its “snake oil” Align probiotic. If the court overturns the lower court, the action could make class action certifications more difficult.

You may also be interested in...



Pharma Securities Fraud Worries Reduced In Supreme Court Omnicare Ruling

High court finds that a corporation’s statement of opinion is not actionable unless company did not sincerely believe it; ruling makes it harder for plaintiffs to file stock fraud claims.

E.l.f. Cosmetics Bold Amid Recession Fears, Forecasting Net Sales Growth Up To 12% In FY 2023

The Gen Z-beloved maker of prestige-inspired cosmetics and skin care at accessible prices has been experiencing strong sales growth in Target stores, increased business online, and remains confident in its prospects even after recently raising products on two-thirds of its portfolio in response to inflationary pressures.

US FTC Section 13(b) Revamp Gains Traction With Senate ‘Fix’ In The Works

There is strong support for a bipartisan fix to discourage marketplace fraud and anticompetitive practices and enable consumer redress under the FTC Act. But Congress is distracted and deeply divided with different ideas about how extensive the FTC’s authorities should be under Section 13(b) of the FTC Act.

Topics

Related Companies

UsernamePublicRestriction

Register

RS108759

Ask The Analyst

Ask the Analyst is free for subscribers.  Submit your question and one of our analysts will be in touch.

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts

Cancel